Validated stability-indicating methods for determination of cilostazol in the presence of its degradation products according to the ICH guidelines
Authors:
- 5 November 2007
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 45 (3) , 407-416
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- High Performance Liquid Chromatographic Analysis of Cilostazol in Human Plasma with On‐Line Column SwitchingJournal of Liquid Chromatography & Related Technologies, 2005
- Liquid chromatography and chemometric methods for determination of rofecoxib in presence of its photodegradate and alkaline degradation productsAnalytica Chimica Acta, 2004
- HPLC Determination of Cilostazol in Tablets, and Its ValidationJournal of Liquid Chromatography & Related Technologies, 2004
- Development of validated stability-indicating assay methods—critical reviewJournal of Pharmaceutical and Biomedical Analysis, 2002
- Concentration Residual Augmented Classical Least Squares (CRACLS): A Multivariate Calibration Method with Advantages over Partial Least SquaresApplied Spectroscopy, 2002
- Method for the quantitative analysis of cilostazol and its metabolites in human plasma using LC/MS/MSJournal of Pharmaceutical and Biomedical Analysis, 2001
- Determination of cilostazol and its metabolites in human urine by high performance liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 2001
- Simultaneous quantitative determination of cilostazol and its metabolites in human plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- The quantitative determination of cilostazol and its four metabolites in human liver microsomal incubation mixtures by high-performance liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 1998
- Simultaneous spectrophotometric determination of mixtures of food colorantsAnalytica Chimica Acta, 1997